How concerned should we be about monkeypox? Plus, Pfizer said three small doses of its vaccine offers strong protection to youngsters under 5, and more COVID news.
Take a look at COVID-19 news from today, May 23, here:Biden says monkeypox not as concerning as CovidUS President Joe Biden said Monday he doesn't believe an outbreak of monkeypox is as risky as the Covid-19 pandemic, tempering comments he made a day earlier that people should be"concerned."
Biden says monkeypox not as concerning as Covid Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer.
, according to preliminary data. That news comes a month after Moderna said it would ask regulators to OK its two doses tor the youngest kids. Healthy Aging WHO chief: The COVID pandemic is 'most certainly not over' Healthy Aging Opponents of federal vaccine mandate seek rehearing Healthy Aging Kim, other N. Koreans attend large funeral amid COVID worry Markets are down, but these charts explain why investors shouldn't panic How child vaccination rates for COVID-19 compare across every state How child vaccination rates for COVID-19 compare across every state #51. Alabama #50. Louisiana #49. Mississippi #48. Wyoming #47.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Pfizer covid shot 80 percent effective in young kids, early data showsThe results, along with other recent developments, signal that the long and frustrating wait for a vaccine for the youngest children, the last group to lack access, could be over within weeks.
Les mer »
Three-dose Covid-19 vaccine produces strong immune response in young children, Pfizer and BioNTech sayThree child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week.
Les mer »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in…
Les mer »
U.S. FDA sets June meeting dates for Moderna, Pfizer small children COVID-19 vaccinesThe U.S. Food and Drug Administration set June 14-15 as the new meeting date to review Moderna Inc's emergency authorization request for its COVID-19 vaccine for children aged 6 months to 5 years and Pfizer Inc's vaccine for those aged 6 months through 4 years.
Les mer »
Pfizer Says Their COVID-19 Vaccine For Kids Under 5 Is 80% Effective Against OmicronPfizer said in preliminary findings in a subset of a clinical trial indicate that 3 doses of the vaccine are 80% effective in preventing symptomatic infection.
Les mer »
Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
Les mer »